Replay available

Organto Foods Inc. (OGO) Q2 2026 Earnings Call

Organto Foods Inc. (TSXV: OGO) Q2 2026 earnings conference call, held 2026-08-13. Replay captured from the company's public earnings webcast.

Thu, August 13, 2026 at 12:00 PMendedReplay
Organto Foods Inc. (OGO) Q2 2026 Earnings Call

Hosted by

Featured presenters

Darryl Bergman

President of Organto Foods

Steve Bromley

CEO and Co-Chair of Organto Foods

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Organto Foods, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.354 Okay, hello, everyone. We'll just give another 00:00:04.357 -- 00:00:07.882 couple seconds to make sure everyone's in. 00:00:07.882 -- 00:00:10.382 And then we will begin. 00:00:13.830 -- 00:00:19.134 Okay, hello everyone and thank you for joining Organto Foods Q2 2026 00:00:19.134 -- 00:00:23.958 results review and business update. My name is Lauren Beck Hansen and I will be moderating 00:00:23.958 -- 00:00:28.502 today's session. We will begin with a brief presentation from Steve Bromley, CEO and 00:00:28.502 -- 00:00:32.665 co-chair of Organto Foods, and Darryl Bergman, president of Organto Foods, who will walk 00:00:32.665 -- 00:00:35.968 through the company's second quarter results and operational highlights. 00:00:35.968 -- 00:00:38.847 Following the presentation, we'll move into the Q&A. 00:00:38.847 -- 00:00:42.813 For those joining via Zoom, you can submit questions at any time using the Q&A function 00:00:42.813 -- 00:00:46.299 at the bottom of your screen. We'll aim to address as many questions as possible, including 00:00:46.299 -- 00:00:49.562 questions that were submitted in advance of today's session. 00:00:49.562 -- 00:00:52.182 Thank you for joining us. 00:01:09.814 -- 00:01:13.395 forward-looking statements are based on management's current expectations assumptions 00:01:13.395 -- 00:01:17.376 estimates and beliefs and are subject to risks and uncertainties that could cause actual 00:01:17.376 -- 00:01:21.618 results to differ materially from those expressed or implied for discussion of these 00:01:21.618 -- 00:01:25.679 risks assumptions uncertainties please refer to organto's public disclosure documents 00:01:25.679 -- 00:01:30.278 including its mdna available under the company's profile on cdar 00:01:30.278 -- ...